Home > Healthcare > Biotechnology > Biotechnology R&D > Cloning and Mutagenesis Market

Cloning and Mutagenesis Market Size

  • Report ID: GMI6030
  • Published Date: Jun 2023
  • Report Format: PDF

Cloning and Mutagenesis Market Size

Cloning and Mutagenesis Market valued at USD 2.9 billion in 2023 and is expected to expand at over 19.4% CAGR between 2024 and 2032. Growing focus on genetic engineering and rising demand for genetically modified products is escalating the growth prospects for the market. Cloning and mutagenesis technologies play a crucial role in the development of precision medicine. Hence, increasing demand for precision medicine has a significant influence on the market demand.

 

Furthermore, rising investments and funding from both public and private sectors, government initiatives, venture capital funding, and collaborations between academic institutions and industry players have fuelled technological advancements and product innovation, thereby positively influencing cloning and mutagenesis market growth.

 

Cloning refers to the creation of identical copies of a particular DNA sequence. In molecular biology, cloning is commonly used to replicate genes or DNA fragments for further analysis or manipulation. Whereas mutagenesis is a technique in which the DNA of an organism is altered or changed, which results in the mutation of the genes. Cloning and mutagenesis methods are used to confirm the mutation effects in vitro and in vivo and study the structure and function of proteins.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of cloning and mutagenesis was USD 2.9 billion in 2023 and is likely to expand at 19.4% CAGR from 2024 to 2032 driven by the growing focus on genetic engineering and rising demand for genetically modified products.

The cloning kits product segment held more than 53% of the Cloning and mutagenesis market share in 2022 and is expected to witness high demand for various applications in gene cloning, protein expression, genetic engineering, and DNA sequencing among others.

North America held over 38.6% of the cloning and mutagenesis industry share in 2022 and is estimated to expand further through 2032 owing to the presence of key market players in the region.

Few top firms engaged in the global market are Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Takara Bio Inc., Merck KGaA, Bio-Rad Laboratories, Inc., Danaher, Jena Bioscience GmbH, New England Biolabs, Promega Corporation, and Assay Genie

Cloning and Mutagenesis Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 14
  • Tables & Figures: 210
  • Countries covered: 20
  • Pages: 120
 Download Free Sample